Dynamic quotes: Off
|
Company Description (as filed with the SEC)
ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing our proprietary controlled cooling technology platform. Our first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. CoolSculpting utilizes precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves, or surrounding tissue. We developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer within a treated fat bulge without requiring the patient to diet or exercise. In our pivotal U.S. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-0.87 |
| Quarterly EPS Est: | -0.17 |
| PEG Ratio: | -.24 |
|
Mean Recommendation: View Summary / View All |
3 |
Data is provided by Zacks Investment Research

